These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11077820)

  • 1. [Chronic viral hepatitis: guidelines for diagnosis and therapy. When to treat--when wait?].
    Füessl HS
    MMW Fortschr Med; 2000 Oct; 142(42):10-1. PubMed ID: 11077820
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease.
    Narváez I; Pérez B; del Mar Alcalde M; Jiménez C; Soria A
    Am J Gastroenterol; 2003 Oct; 98(10):2336-7. PubMed ID: 14572601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic viral hepatitis B and C. Hysteria and panic are no longer appropriate].
    Schwerdtfeger M; Fleig WE
    MMW Fortschr Med; 2000 Nov; 142(46):39-42. PubMed ID: 11132310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon plus ribavirin: a cautionary note.
    Macedo G; Ribeiro T
    Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of viral hepatitis in children].
    Kekez AJ
    Acta Med Croatica; 2005; 59(5):463-7. PubMed ID: 16381244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.
    van Leeuwen DJ; Yee LJ; Langner RG
    Am J Gastroenterol; 2002 Feb; 97(2):497-8. PubMed ID: 11866304
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
    Juszczyk J; Bolewska B; Flieger J; Swietek K; Adamek B; Biskupska-Karasińska M; Dziambor AP; Boroń-Kaczmarska A; Wawrzynowicz-Syczewska M; Cianciara J; Kozłowska J; Daniluk J; Słomka M; Dudziak M; Zaborowski P; Gładysz A; Piszko P; Gonciarz Z; Mazur W; Machniak M; Kryczka W; Zarebska-Michaluk D; Trocha H; Witczak-Malinowska K; Lakomy E; Kuydowicz J; Niwicka-Michałowska A
    Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic progresses of hepatitis C].
    Ma QY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):501-2. PubMed ID: 12939190
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of patients with chronic hepatitis C who have not been previously treated].
    Marcellin P; Boyer N
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B194-201. PubMed ID: 12180288
    [No Abstract]   [Full Text] [Related]  

  • 15. [New strategies for treatment of chronic hepatitis C].
    Rizzetto M
    Forum (Genova); 1999; 9(2 Suppl):1-11. PubMed ID: 11300125
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
    Sulka A; Simon K; Jeleń M; Piszko P
    Przegl Epidemiol; 2005; 59(2):455-66. PubMed ID: 16190554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
    Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R
    J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.